Evidence map›Paper›PMID 27680175›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2016

SEROPREVALENCE AND RISK FACTORS ASSOCIATED WITH Toxoplasma gondii INFECTION AMONG RURAL COMMUNITIES IN NORTHERN IRAN.

Ali Rostami, Seyyed Javad Seyyedtabaei, Somayeh Aghamolaie, Hamed Behniafar, Zohreh Lasjerdi, Alireza Abdolrasouli, Saeed Mehravar, Cosme Alvarado-Esquivel

Abstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. The global seroprevalence ofThe veterinary quarterly · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modeling the human placental barrier to understandFrontiers in cellular and infection microbiology · 2023
    Review
  11. Prevalence ofPathogens (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Seroprevalence and Risk Factors Associated withJournal of parasitology research · 2022
    Article
  14. High Seroprevalence ofAnimals : an open access journal from MDPI · 2021
    Article
  15. Article
  16. Article
  17. Occurrence ofParasitology · 2020
    Article
  18. Article
  19. Parasite epidemiology and control · 2019
    Article
  20. Seroepidemiological evaluation ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ali RostamiDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences. Tehran, Iran. E-mails: alirostami1984@gmail.com; Seyyedtabaei@gmail.com; saghamolaie@yahoo.com; hbehniyafar@gmail.com; Zohrehlasjerdi@gmail.com.
Seyyed Javad SeyyedtabaeiDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences. Tehran, Iran. E-mails: alirostami1984@gmail.com; Seyyedtabaei@gmail.com; saghamolaie@yahoo.com; hbehniyafar@gmail.com; Zohrehlasjerdi@gmail.com.
Somayeh AghamolaieDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences. Tehran, Iran. E-mails: alirostami1984@gmail.com; Seyyedtabaei@gmail.com; saghamolaie@yahoo.com; hbehniyafar@gmail.com; Zohrehlasjerdi@gmail.com.
Hamed BehniafarDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences. Tehran, Iran. E-mails: alirostami1984@gmail.com; Seyyedtabaei@gmail.com; saghamolaie@yahoo.com; hbehniyafar@gmail.com; Zohrehlasjerdi@gmail.com.
Zohreh LasjerdiDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences. Tehran, Iran. E-mails: alirostami1984@gmail.com; Seyyedtabaei@gmail.com; saghamolaie@yahoo.com; hbehniyafar@gmail.com; Zohrehlasjerdi@gmail.com.
Alireza AbdolrasouliDepartment of Medical Microbiology, Charing Cross Hospital, Imperial College Healthcare NHS Trust. London, United Kingdom. E-mail: a.abdolrasouli@imperial.ac.uk.
Saeed MehravarDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science. Tehran, Iran. E-mail: saeed.mehravar@gmail.com.
Cosme Alvarado-EsquivelBiomedical Research Laboratory, Faculty of Medicine and Nutrition, Juárez University of Durango State. Avenida Universidad S/N, 34000 Durango, Dgo, Mexico. E-mail: alvaradocosme@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis is the fourth most common cause of hospitalization and the second cause of death due to food-borne infections. We conducted a cross-sectional study to determine the prevalence, disease awareness and risk factors associated with toxoplasmosis among rural communities in Northern Iran. Data were obtained from serological testing and from participant's questionnaires and were analyzed using a logistic regression. Of the 630 participants, 465 (73.8%), and 12 (1.9%) had IgG and both IgG and IgM anti-Toxoplasma gondii antibodies, respectively. In the logistic regression analysis, T. gondii seropositivity was associated with the following factors: age, occupation, consumption of undercooked meat, and of unwashed raw vegetables or fruits (p < 0.001). Our study showed a high prevalence of T. gondii infection in the general population of Northern Iran. A health program is needed to increase the public awareness of toxoplasmosis, and its associated risk factors.

Identifiers

PMID27680175
PMCPMC5048641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.